Abstract:The melanocortin 1 receptor (MC1R) is a highly polymorphic G protein-coupled receptor, which is known to modulate pigmentation and inflammation. In the current study, we investigated the pharmacological effects of select single-nucleotide polymorphisms (SNPs) (V60L, R163Q, and F196L). After transient expression of MC1Rs in human embryonic kidney 293 cells, basal and ligand-induced cAMP signaling and mitogen-activated protein kinase (MAPK) activation were assessed by using luciferase reporter gene assays and Western blot analysis, respectively. All receptor variants showed decreased basal cAMP activity. With the V60L and F196L variants, the decrease in constitutive activity was attributable, at least in part, to a reduction in surface expression. The F196L variant also displayed a significant reduction in potency for both the peptide agonist α-melanocyte-stimulating hormone (α-MSH) and the small-molecule agonist 1-[1-(3-methyl-L-histidyl-O-methyl-D-tyrosyl)-4-phenyl-4-piperidinyl]-1-butanone (BMS-470539). In MAPK signaling assays, the F196L variant showed decreased phospho-extracellular signal-regulated kinase levels after stimulation with either α-MSH or BMS-470539. In contrast, the R163Q variant displayed a selective loss of α-MSH-induced MAPK activation; whereas responsiveness to the small-molecule agonist BMS-470539 was preserved. Further assessment of MC1R variants in A549 cells, an in vitro model of inflammation, revealed an enhanced inflammatory response resulting from expression of the F196L variant (versus the wild-type MC1R). This alteration in function was restored by treatment with BMS-470539. Overall, these studies illustrate novel signaling profiles linked to distinct MC1R SNPs. Furthermore, our investigations highlight the potential for small-molecule drugs to rescue the function of MC1R variants that show reduced basal and/or α-MSH stimulated activity.

Pharmacological Modulation of the Camp Signaling of Two Isoforms of Melanocortin-3 Receptor by Melanocortin Receptor Accessory Proteins in the Tetrapod Xenopus Laevis

Pharmacological Modulation Of Dual Melanocortin-4 Receptor Signaling By Melanocortin Receptor Accessory Proteins In The Xenopus Laevis

Pharmacological Modulation of Melanocortin 1 Receptor Signaling by Mrap Proteins in Xenopus tropicalis

Pharmacological evaluation of MRAP proteins on Xenopus neural melanocortin signaling

Pharmacological Evaluation of Melanocortin 2 Receptor Accessory Protein 2 on Axolotl Neural Melanocortin Signaling

Pharmacological Modulation of MRAP2 Protein on Melanocortin Receptors in the Sea Lamprey

Pharmacological Modulation of Melanocortin-4 Receptor by Melanocortin Receptor Accessory Protein 2 in Nile Tilapia.

Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein

Pharmacological Modulation of Two Melanocortin-5 Receptors by MRAP2 Proteins in Zebrafish

Pharmacological Effect of Human Melanocortin-2 Receptor Accessory Protein 2 Variants on Hypothalamic Melanocortin Receptors

Evolutionary Identification of the Requirement of the Second Intracellular Loop for the Constitutive Activity of Melanocortin-4 Receptors

Reversion of MRAP2 Protein Sequence Generates a Functional Novel Pharmacological Modulator for MC4R Signaling

Characterization of Channel Catfish (ictalurus Punctatus) Melanocortin-3 Receptor Reveals a Potential Network in Regulation of Energy Homeostasis.

Regulation of melanocortin-1 receptor pharmacology by melanocortin receptor accessory protein 2 in orange-spotted grouper (Epinephelus coioides)

Selective Interactions of Mouse Melanocortin Receptor Accessory Proteins with Somatostatin Receptors

Structural basis of signaling regulation of the human melanocortin-2 receptor by MRAP1

The Interaction of MC3R and MC4R with MRAP2a in Rainbow Trout ( Oncorhynchus Mykiss )

Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors

Mechanism of N-terminal modulation of activity at the melanocortin-4 receptor GPCR

MRAP2 modifies signaling and oligomerization state of the melanocortin-4 receptor

Selected melanocortin 1 receptor single-nucleotide polymorphisms differentially alter multiple signaling pathways